Skip to main content
Erschienen in: Annals of Nuclear Medicine 10/2015

01.12.2015 | Original Article

Evaluation of bone scan index change over time on automated calculation in bone scintigraphy

verfasst von: Rini Shintawati, Arifudin Achmad, Tetsuya Higuchi, Hirotaka Shimada, Hiromi Hirasawa, Yukiko Arisaka, Ayako Takahashi, Takahito Nakajima, Yoshito Tsushima

Erschienen in: Annals of Nuclear Medicine | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

Bone scintigraphy (bone scan) is useful in detecting metastatic bone lesions through visual assessment of hot spots. A semi-quantitative analysis method that evaluates bone scan images has been eagerly anticipated. BONENAVI is software that enables automatic assessment of bone scan index (BSI). BSI is useful for stratifying cancer patients and monitoring their therapeutic response. The purpose of this study was to evaluate the BONENAVI reading in determining BSI and hot spots at different time intervals after radioisotope injection.

Methods

We evaluated 32 patients, including 22 males and 10 females. Ten patients had breast cancer, 20 patients had prostate cancer, and 2 had malignant pheochromocytoma. Patients were injected with 740 MBq of 99mTc-methylene diphosphonate and bone scintigraphy was performed at 2, 4, and 6 h after injection on each patient. The BSI and the number of hot spots were obtained from BONENAVI software. Bone scan images were also visually assessed to exclude false positives due to artifacts. Analyses were performed in all lesions, selected true lesions, segment based and cancer type based. Non-parametric statistical analyses for pairwise multiple group comparison were performed using Friedman test followed with post hoc analysis.

Results

The BSIs and the number of hot spots were significantly increased with time, with significant differences between each of time points (P < 0.001). Analysis of regional BSI (rBSI) and hot spot number changes of selected 15 true lesions also showed similar increase (P < 0.001). In general, the pelvic segment was the most prone to rBSI changes and the chest segment was the most prone to hot spot number changes. Visual assessment showed that BONENAVI diagnosed some typical artifacts as metastases (hot spots).

Conclusion

BONENAVI reading of BSIs and hot spot numbers was highly affected by acquisition time. In serial or follow-up examinations (in particular, for monitoring therapeutic efficacy), acquisition time should be fixed for each patient. Cautious interpretation should be made on segments with high physiological uptake. BONENAVI reading was prone to misinterpretation of artifacts. Visual assessment is necessary to rule out this possibility.
Literatur
1.
Zurück zum Zitat Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–9s.CrossRefPubMed Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–9s.CrossRefPubMed
2.
Zurück zum Zitat Erdi YE, Humm JL, Imbriaco M, Yeung H, Larson SM. Quantitative bone metastases analysis based on image segmentation. J Nucl Med. 1997;38:1401–6.PubMed Erdi YE, Humm JL, Imbriaco M, Yeung H, Larson SM. Quantitative bone metastases analysis based on image segmentation. J Nucl Med. 1997;38:1401–6.PubMed
3.
Zurück zum Zitat Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clin Cancer Res. 1998;4:1765–72.PubMed Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clin Cancer Res. 1998;4:1765–72.PubMed
4.
Zurück zum Zitat Sadik M, Suurkula M, Hoglund P, Jarund A, Edenbrandt L. Quality of planar whole-body bone scan interpretations—a nationwide survey. Eur J Nucl Med Mol Imaging. 2008;35:1464–72.CrossRefPubMed Sadik M, Suurkula M, Hoglund P, Jarund A, Edenbrandt L. Quality of planar whole-body bone scan interpretations—a nationwide survey. Eur J Nucl Med Mol Imaging. 2008;35:1464–72.CrossRefPubMed
5.
Zurück zum Zitat Sadik M, Hamadeh I, Nordblom P, Suurkula M, Hoglund P, Ohlsson M, et al. Computer-assisted interpretation of planar whole-body bone scans. J Nucl Med. 2008;49:1958–65.CrossRefPubMed Sadik M, Hamadeh I, Nordblom P, Suurkula M, Hoglund P, Ohlsson M, et al. Computer-assisted interpretation of planar whole-body bone scans. J Nucl Med. 2008;49:1958–65.CrossRefPubMed
6.
Zurück zum Zitat Agatonovic-Kustrin S, Beresford R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal. 2000;22:717–27.CrossRefPubMed Agatonovic-Kustrin S, Beresford R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal. 2000;22:717–27.CrossRefPubMed
7.
Zurück zum Zitat Tokuda O, Harada Y, Ohishi Y, Matsunaga N, Edenbrandt L. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients. Ann Nucl Med. 2014;28:329–39.CrossRefPubMed Tokuda O, Harada Y, Ohishi Y, Matsunaga N, Edenbrandt L. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients. Ann Nucl Med. 2014;28:329–39.CrossRefPubMed
8.
Zurück zum Zitat Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur Urol. 2012;62:78–84.PubMedCentralCrossRefPubMed Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur Urol. 2012;62:78–84.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Wakabayashi H, Nakajima K, Mizokami A, Namiki M, Inaki A, Taki J, et al. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases. Ann Nucl Med. 2013;27:802–7.CrossRefPubMed Wakabayashi H, Nakajima K, Mizokami A, Namiki M, Inaki A, Taki J, et al. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases. Ann Nucl Med. 2013;27:802–7.CrossRefPubMed
10.
Zurück zum Zitat Kikuchi A, Onoguchi M, Horikoshi H, Sjostrand K, Edenbrandt L. Automated segmentation of the skeleton in whole-body bone scans: influence of difference in atlas. Nucl Med Commun. 2012;33:947–53.CrossRefPubMed Kikuchi A, Onoguchi M, Horikoshi H, Sjostrand K, Edenbrandt L. Automated segmentation of the skeleton in whole-body bone scans: influence of difference in atlas. Nucl Med Commun. 2012;33:947–53.CrossRefPubMed
11.
Zurück zum Zitat Nakajima K, Nakajima Y, Horikoshi H, Ueno M, Wakabayashi H, Shiga T, et al. Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: a Japanese multi-center database project. EJNMMI Res. 2013;3:83.PubMedCentralCrossRefPubMed Nakajima K, Nakajima Y, Horikoshi H, Ueno M, Wakabayashi H, Shiga T, et al. Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: a Japanese multi-center database project. EJNMMI Res. 2013;3:83.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Donohoe KJ, Henkin RE, Royal HD, Brown ML, Collier BD, O’Mara RE, et al. Procedure guideline for bone scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med. 1996;37:1903–6.PubMed Donohoe KJ, Henkin RE, Royal HD, Brown ML, Collier BD, O’Mara RE, et al. Procedure guideline for bone scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med. 1996;37:1903–6.PubMed
13.
Zurück zum Zitat Bombardieri E, Aktolun C, Baum R, Bishof-Delaloye A, Buscombe J, Chatal J, et al. Bone scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:B99–106. Bombardieri E, Aktolun C, Baum R, Bishof-Delaloye A, Buscombe J, Chatal J, et al. Bone scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:B99–106.
14.
Zurück zum Zitat Saha GB. Fundamentals of nuclear pharmacy. New York: Springer Science + Business Media; 2010. p. 297.CrossRef Saha GB. Fundamentals of nuclear pharmacy. New York: Springer Science + Business Media; 2010. p. 297.CrossRef
15.
Zurück zum Zitat Karesh SM. Principles of radiopharmacy. In: Henkin RE, editor. Nuclear medicine. 2nd ed. Michigan: Mosby Elsevier; 2006. p. 334. Karesh SM. Principles of radiopharmacy. In: Henkin RE, editor. Nuclear medicine. 2nd ed. Michigan: Mosby Elsevier; 2006. p. 334.
16.
Zurück zum Zitat Rosenthall L, Arzoumanian A, Damtew BU, Tremblay J. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients. Clin Nucl Med. 1981;6:353–5.CrossRefPubMed Rosenthall L, Arzoumanian A, Damtew BU, Tremblay J. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients. Clin Nucl Med. 1981;6:353–5.CrossRefPubMed
17.
Zurück zum Zitat Van Duzee BF, Schaefer JA, Ball JD, Chilton HM, Cowan RJ, Kuni C, et al. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. J Nucl Med. 1984;25:166–9.PubMed Van Duzee BF, Schaefer JA, Ball JD, Chilton HM, Cowan RJ, Kuni C, et al. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. J Nucl Med. 1984;25:166–9.PubMed
18.
Zurück zum Zitat Lecouvet FE, Talbot JN, Messiou C, Bourguet P, Liu Y, de Souza NM, et al. Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer. 2014;50:2519–31.CrossRefPubMed Lecouvet FE, Talbot JN, Messiou C, Bourguet P, Liu Y, de Souza NM, et al. Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer. 2014;50:2519–31.CrossRefPubMed
19.
Zurück zum Zitat Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202.CrossRefPubMed Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202.CrossRefPubMed
20.
Zurück zum Zitat Gnanasegaran G, Cook G, Fogelman I. Musculoskeletal system. In: Biersack H, Freeman LM, editors. Clinical nuclear medicine. Heidelberg: Springer-Verlag; 2007. p. 241.CrossRef Gnanasegaran G, Cook G, Fogelman I. Musculoskeletal system. In: Biersack H, Freeman LM, editors. Clinical nuclear medicine. Heidelberg: Springer-Verlag; 2007. p. 241.CrossRef
21.
Zurück zum Zitat Weiner RE. Bone imaging radiopharmaceutical. In: Henkin RE, editor. Nuclear medicine. Michigan: Mosby Elsevier; 2006. p. 1117. Weiner RE. Bone imaging radiopharmaceutical. In: Henkin RE, editor. Nuclear medicine. Michigan: Mosby Elsevier; 2006. p. 1117.
22.
Zurück zum Zitat Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 2015;29:138–48.CrossRefPubMed Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 2015;29:138–48.CrossRefPubMed
23.
Zurück zum Zitat Yoneyama S, Miyoshi Y, Takebayashi S, Noguchi K. Prognostic value of computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases. Ann Oncol. 2014;25:276–7.CrossRef Yoneyama S, Miyoshi Y, Takebayashi S, Noguchi K. Prognostic value of computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases. Ann Oncol. 2014;25:276–7.CrossRef
24.
Zurück zum Zitat Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasms with incidence and localization of skeletal metastases: an analysis of 1355 diphosphonate bone scans. J Nucl Med. 1975;16:986–9.PubMed Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasms with incidence and localization of skeletal metastases: an analysis of 1355 diphosphonate bone scans. J Nucl Med. 1975;16:986–9.PubMed
25.
Zurück zum Zitat Iwase T, Yamamoto N, Ichihara H, Togawa T, Nagashima T, Miyazaki M. The relationship between skeletal-related events and bone scan index for the treatment of bone metastasis with breast cancer patients. Medicine (Baltimore). 2014;93:e269.CrossRef Iwase T, Yamamoto N, Ichihara H, Togawa T, Nagashima T, Miyazaki M. The relationship between skeletal-related events and bone scan index for the treatment of bone metastasis with breast cancer patients. Medicine (Baltimore). 2014;93:e269.CrossRef
26.
Zurück zum Zitat Coakley FV, Jones AR, Finlay DB, Belton IP. The aetiology and distinguishing features of solitary spinal hot spots on planar bone scans. Clin Radiol. 1995;50:327–30.CrossRefPubMed Coakley FV, Jones AR, Finlay DB, Belton IP. The aetiology and distinguishing features of solitary spinal hot spots on planar bone scans. Clin Radiol. 1995;50:327–30.CrossRefPubMed
Metadaten
Titel
Evaluation of bone scan index change over time on automated calculation in bone scintigraphy
verfasst von
Rini Shintawati
Arifudin Achmad
Tetsuya Higuchi
Hirotaka Shimada
Hiromi Hirasawa
Yukiko Arisaka
Ayako Takahashi
Takahito Nakajima
Yoshito Tsushima
Publikationsdatum
01.12.2015
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 10/2015
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-015-1021-3

Weitere Artikel der Ausgabe 10/2015

Annals of Nuclear Medicine 10/2015 Zur Ausgabe